VCRE
Vicore ABDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
VCRE vs peer average
54/100
VCRE vs. peer average (D vs. D)
Grade spread
C 3 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
FULC is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $287.64M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
VCRE
Vicore AB
FULC
Fulcrum Therapeutics
Grade
D
C
Momentum
0
36
Value
49
58
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs FULC
VCRE / FULC
Grade Position
In line
VCRE vs. peer average (D vs. D)
54/100
Momentum
0
FULCValue
49
FULCSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs VCRE
FULC is the first peer returned for this comparison set.